Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers
- PMID: 22973320
- PMCID: PMC3430016
Relation of resistin levels with C-reactve protein, homocysteine and uric acid in smokers and non-smokers
Abstract
Background: The association between C-reactive protein, homocysteine, uric acid levels and cardiovascular risk have been debated for decades. Resistin is a newly discovered adipocyte derived cytokine. Smoking besides its effect on atherosclerosis, is shown to alter adipocytokine levels. Bearing in mind, these complex relationship of resistin with smoking, C-reactive protein, homocysteine and uric acid, we planned to investigate the association of resistin and these cardiovascular risk factors in smoker and non-smoker subjects.
Methods: We conducted a cross-sectional randomized study including 52 smoking and 33 non-smoking men. After making comparisons of C-reactive protein, homocysteine, uric acid and resistin between the two groups, we classified the subjects according to their insulin resistance and body mass and made again the comparisons..
Results: Resistin levels were higher in smokers than in non-smokers (p<0.001) and also in insulin resistant than in non-insulin resistant smokers (p<0.05). Resistin levels were indifferent in non-smokers as insulin resistance was concerned and in smoker or non-smokers as body mass index was concerned. As all subjects were grouped based on homeostasis model assesment index and body mass index, neither C-reactive protein nor homocysteine and uric acid levels differred.
Conclusions: We found that smoking may have influence on resistin levels and in smokers, insulin resistance is related to resistin levels, but in smoker and non-smokers body mass may not have any association with resistin. Resistin also may not have a role in C-reactive protein, homocysteine and uric acid levels both in smokers and non-smokers.
Keywords: CRP; Homocysteine; Resistin; Smoking; Uric Acid.
Conflict of interest statement
Similar articles
-
Relation of resistın wıth obesity and some cardiovascular risk factors in hypertensive women.J Res Med Sci. 2012 May;17(5):443-7. J Res Med Sci. 2012. PMID: 23626608 Free PMC article.
-
Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.Gynecol Endocrinol. 2010 Mar;26(3):161-6. doi: 10.3109/09513590903247816. Gynecol Endocrinol. 2010. PMID: 20148738
-
The relation of obesity with serum resistin levels in smoker and nonsmokers.J Res Med Sci. 2012 Feb;17(2):119-22. J Res Med Sci. 2012. PMID: 23264782 Free PMC article.
-
Plasma resistin levels are associated with homocysteine, endothelial activation, and nitrosative stress in obese youths.Clin Biochem. 2014 Jan;47(1-2):44-8. doi: 10.1016/j.clinbiochem.2013.10.021. Epub 2013 Oct 29. Clin Biochem. 2014. PMID: 24183883
-
Relationships between human serum resistin, inflammatory markers and insulin resistance.Int J Obes (Lond). 2005 Nov;29(11):1315-20. doi: 10.1038/sj.ijo.0803037. Int J Obes (Lond). 2005. PMID: 16044175
Cited by
-
Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction.Dis Markers. 2018 Oct 10;2018:3406028. doi: 10.1155/2018/3406028. eCollection 2018. Dis Markers. 2018. PMID: 30405857 Free PMC article. Review.
-
Serum resistin: A possible link between inflammation, hypertension and coronary artery disease.Pak J Med Sci. 2019;35(3):641-646. doi: 10.12669/pjms.35.3.274. Pak J Med Sci. 2019. PMID: 31258568 Free PMC article.
-
Association of cardiac rehabilitation with improvement in high sensitive C-reactive protein post-myocardial infarction.Iran Red Crescent Med J. 2012 Jan;14(1):49-50. Epub 2012 Jan 1. Iran Red Crescent Med J. 2012. PMID: 22737555 Free PMC article. No abstract available.
-
Serum resistin levels may be new prognostic factor of crimean-congo hemorrhagic fever.Int J Clin Exp Med. 2014 Oct 15;7(10):3536-42. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25419394 Free PMC article.
References
-
- Luomala M, Paiva H, Thelen K, Laaksonen R, Saarela M, Mattila K, et al. Osteopontin levels are associated with cholesterol synthesis markers in mildly hypercholesterolaemic patients. Acta Cardiol. 2007;62(2):177–81. - PubMed
-
- Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit. The verdict is still out? Circulation. 2006;113(17):2128–34. - PubMed
-
- Hingorani AD, Shah T, Casas JP. Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. Eur Heart J. 2006;27(11):1261–3. - PubMed
-
- Miller M, Zhan M, Havas S. High attributable risk of elevated Linking observational and genetic approaches to determine the role of C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2005;165(18):2063–8. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous